AG
OCDX

Algert Global’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Algert Global’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-55,417
Closed -$1.03M – 1446
2022
Q1 		$1.03M Buy
55,417
+28,789
+108% +$518K 0.07% 511
2021
Q4 		$570K Buy
+26,628
New +$525K 0.07% 486

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Algert Global's OCDX Position: Q2 2022 in Review

Algert Global sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 55,417 shares — an estimated $1.03M sold.

Algert Global first reported a position in OCDX in Q4 2021 and held it in 2 quarters. The position peaked at $1.03M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Algert Global reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Algert Global sold 55,417 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $1.03M.
  • Algert Global first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 2 quarters.
  • Algert Global's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.03M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Algert Global's 13F filing for Q2 2022, filed 15 Aug 2022.